LVO usually does not require treatment or cause serious symptoms. However, treatment may be an option for those concerned with the appearance of the LVO in the language, or who have disseminated lesions and experience discomfort or taste changes due to the plates.

The usual method for treating viral LVO is taken orally (by mouth). Usually, these medicines are taken for one to two weeks or until the plates of the LVO disappear.
Other options include tretinoin (Retin A) and podophyllin resin, two drugs that can be applied directly to the plates of LVO. Usually tretinoin is applied two or three times a day until the plates are gone. Podophyllin it operates a health care provider once or twice during a period of two to three weeks. Other options, especially if the plates are small, is that a healthcare provider applies liquid nitrogen (cryotherapy) to the affected area, or surgery to remove the plates.

Can you prevent the LVO?

There is no sure way to prevent the plates of the LVO. However, the best way to prevent it can be to maintain healthy immune system. This means keeping viral load low and high T cells, using anti-HIV treatment, and adopting a healthy lifestyle.

Is there any treatment for developing LVO?

Currently, there are drugs in development to treat LVO as an opportunistic infection is not serious, and that there are medications to treat it. If you are interested in participating in any clinical trials with new therapies for the treatment or prevention of LVO, there is an interactive site aimed for finding clinical trials is AIDSinfo.nih.gov a site run by the National Institutes of Health United States (National Institutes of Health). These pages are “specialists in health information, with whom you can communicate by calling toll free 1-800-HIV-0440 (1-800-448-0440).

Morphine is a drug that is routinely provided to cancer patients to relieve pain. Recent studies conducted in the laboratory suggest that morphine may stimulate the spread of the disease. The researchers said this opioid promotes the growth of new blood vessels that carry oxygen and nutrients to tumors.

The scientists, who presented their findings during the joint conference of the American Association of Cancer Research and the European Organization for Research and Treatment of Cancer, held in Boston, also reported the discovery of a new drug that could counteract this effect. Experts say, however, that more testing is needed before carrying out any change in treatment.

The two new studies by the University of Chicago found that lung cancer by protecting cells from the effect of opioids will reduce the proliferation and cell migration. Dr. Patrick Singleton, head of the studies reported that in laboratory tests morphine not only strengthened but blood vessels appeared to facilitate the invasion and spread of cancer cells to other tissues. However, it appears that this can be overcome with another drug, called naltrexone, or methyl-MNTX.

Morphine, a potent opioid analgesic, has been for over two centuries, the standard treatment to combat chronic pain of cancer patients. Since research is in its early stages is not yet say whether opioid-based painkillers have an effect on cancer growth. Therefore, we must continue with studies.

Use the best fat burner pills to burn your weight!

Incoming search terms for the article:

The use of deodorant could affect the growth of breast cancer in women: no scientific studies have demonstrated this possibility. A group of experts from the French Cancer Society made a detailed and scientific analysis on this subject. Conclusion: No scientific evidence has been identified for this hypothesis.

Breast Cancer: deodorants Charged

Several studies have noted a high incidence of breast cancer at the area close to the application of anti-perspirant deodorant (the upper outer quadrant) and use more and more frequent these products.

Based on these findings, several research teams have sought to establish a possible link between antiperspirants and breast cancer. The assumption most played retained the possible role of parabens and aluminum salts. However, to date, no prospective epidemiological study has demonstrated the hypothesis that the use of deodorants had an impact on the growth of breast cancer in women.

No scientific evidence

A group of experts whose findings were published in the journal Cancer Bulletin, Official Organ of the French Cancer Society, gave a detailed scientific analysis to address the anxiety of women on this subject. They were well reviewed 59 studies from the literature and 19 items of different methodology. Their conclusion? No scientific evidence for the hypothesis could not be identified. Moreover, these experts explain that there remains no validated hypothesis may open up channels of interesting research. They argue that this issue does not constitute a public health problem and it seems pointless to continue research on this topic.

The French Agency for Sanitary Safety of Health Products (AFSSAPS) was published in 2006 from information in the same direction. Thus, no reason for concern about the use of any deodorant.

The importance of screening for breast cancer

The known risk factors for breast cancer? A minority of breast cancers is related to a family who inherited form occurs most often at a young age, one of the major risk factors remaining estrogen. Thus prevention of this scourge women based primarily on the screening mammography.

Breast cancer remains the most common cancer of women in Western countries: it affects one in nine women, mostly after menopause. It caused 11 000 deaths in France in 2005. More breast cancer is detected early, the greater the chances of recovery are important. With early detection, half of breast cancers are detected when they are less than 2 cm. This level of detection can reach very high cure rates while substantially reducing the aggressiveness of treatment applied. At any age, you must be regularly monitored by a doctor or a gynecologist who will prescribe the necessary examinations, particularly if it considers that you have family risk factors for breast cancer. This medical must be conducted every 6 months or every year from 30 years.

In France, the organized screening (every two years, a mammogram supported 100% by the Health Insurance without advance fee) is available to women from 50 years to 74 years. Against breast cancer, go for screening!